Dr. Velasco Díez is a global authority on autophagy and cannabinoid signaling, exploring their potential to treat aggressive brain tumors through personalized molecular targeting.

Academic Titles & Degrees: PhD in Biochemistry and Molecular Biology (Complutense University of Madrid).

Current Executive & Clinical Appointments:  Full Professor at Complutense University; President of the Spanish Society for Autophagy Research (SEFAGIA).

Research Axes & Leadership: Elucidating cannabinoid antitumor activity; personalized glioblastoma therapies targeting the MDK/ALK axis; FLASH radiotherapy research using tissue-on-chip devices.

High-Impact Publications & Awards:   Nature Reviews Cancer, Cancer Cell, Nature Cell Biology, EMBO Journal, Journal of Experimental Medicine.